CYRX — CryoPort Cashflow Statement
0.000.00%
- $287.48m
- $261.22m
- $228.39m
- 61
- 61
- 26
- 47
Annual cashflow statement for CryoPort, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -32.7 | -276 | -37.3 | -99.6 | -115 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 10.2 | 270 | 41.1 | 72.5 | 76.3 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.75 | -7.19 | -28 | 0.78 | -8.23 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | -14.9 | 8.13 | -1.85 | -0.757 | -16.3 |
Capital Expenditures | -9.67 | -25 | -24.2 | -44.9 | -21.3 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Software Development Costs | |||||
Other Investing Cash Flow Items | -373 | -444 | -35.5 | 80.9 | 198 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -382 | -469 | -59.7 | 36 | 177 |
Financing Cash Flow Items | -4.12 | 0 | 0 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 386 | 564 | -39.2 | -23.8 | -162 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -10.4 | 102 | -103 | 9.75 | -1.06 |